These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12057656

  • 1. Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives.
    Madhavan GR, Chakrabarti R, Vikramadithyan RK, Mamidi RN, Balraju V, Rajesh BM, Misra P, Kumar SK, Lohray BB, Lohray VB, Rajagopalan R.
    Bioorg Med Chem; 2002 Aug; 10(8):2671-80. PubMed ID: 12057656
    [Abstract] [Full Text] [Related]

  • 2. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR, Chakrabarti R, Kumar SK, Misra P, Mamidi RN, Balraju V, Kasiram K, Babu RK, Suresh J, Lohray BB, Lohrayb VB, Iqbal J, Rajagopalan R.
    Eur J Med Chem; 2001 Aug; 36(7-8):627-37. PubMed ID: 11600232
    [Abstract] [Full Text] [Related]

  • 3. PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes.
    Chakrabarti R, Vikramadithyan RK, Kumar MP, Kumar SK, Mamidi NV, Misra P, Suresh J, Hiriyan J, Rao CS, Rajagopalan R.
    Diabetes Obes Metab; 2002 Sep; 4(5):319-28. PubMed ID: 12190995
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
    Reddy KA, Lohray BB, Bhushan V, Reddy AS, Rao Mamidi NV, Reddy PP, Saibaba V, Reddy NJ, Suryaprakash A, Misra P, Vikramadithyan RK, Rajagopalan R.
    J Med Chem; 1999 Aug 26; 42(17):3265-78. PubMed ID: 10464013
    [Abstract] [Full Text] [Related]

  • 6. Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity.
    Sauerberg P, Pettersson I, Jeppesen L, Bury PS, Mogensen JP, Wassermann K, Brand CL, Sturis J, Wöldike HF, Fleckner J, Andersen AS, Mortensen SB, Svensson LA, Rasmussen HB, Lehmann SV, Polivka Z, Sindelar K, Panajotova V, Ynddal L, Wulff EM.
    J Med Chem; 2002 Feb 14; 45(4):789-804. PubMed ID: 11831892
    [Abstract] [Full Text] [Related]

  • 7. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
    Lohray BB, Bhushan V, Reddy AS, Rao PB, Reddy NJ, Harikishore P, Haritha N, Vikramadityan RK, Chakrabarti R, Rajagopalan R, Katneni K.
    J Med Chem; 1999 Jul 15; 42(14):2569-81. PubMed ID: 10411477
    [Abstract] [Full Text] [Related]

  • 8. Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
    Vikramadithyan RK, Chakrabarti R, Misra P, Premkumar M, Kumar SK, Rao CS, Ghosh A, Reddy KN, Uma C, Rajagopalan R.
    Metabolism; 2000 Nov 15; 49(11):1417-23. PubMed ID: 11092504
    [Abstract] [Full Text] [Related]

  • 9. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB, Bhushan V, Rao BP, Madhavan GR, Murali N, Rao KN, Reddy AK, Rajesh BM, Reddy PG, Chakrabarti R, Vikramadithyan RK, Rajagopalan R, Mamidi RN, Jajoo HK, Subramaniam S.
    J Med Chem; 1998 May 07; 41(10):1619-30. PubMed ID: 9572887
    [Abstract] [Full Text] [Related]

  • 10. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K, Tobe K, Ide T, Mochizuki T, Ohashi M, Akanuma Y, Yazaki Y, Kadowaki T.
    Diabetes; 1998 Dec 07; 47(12):1841-7. PubMed ID: 9836514
    [Abstract] [Full Text] [Related]

  • 11. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).
    Sohda T, Ikeda H, Meguro K.
    Chem Pharm Bull (Tokyo); 1995 Dec 07; 43(12):2168-72. PubMed ID: 8582019
    [Abstract] [Full Text] [Related]

  • 12. Phenylacetic acid derivatives as hPPAR agonists.
    Santini C, Berger GD, Han W, Mosley R, MacNaul K, Berger J, Doebber T, Wu M, Moller DE, Tolman RL, Sahoo SP.
    Bioorg Med Chem Lett; 2003 Apr 07; 13(7):1277-80. PubMed ID: 12657263
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivation.
    Kurosaki E, Nakano R, Shimaya A, Yoshida S, Ida M, Suzuki T, Shibasaki M, Shikama H.
    Biochem Pharmacol; 2003 Mar 01; 65(5):795-805. PubMed ID: 12628477
    [Abstract] [Full Text] [Related]

  • 14. [The thiazolidinedione derivates: a new class of oral blood glucose lowering agents].
    Jazet IM, Meinders AE.
    Ned Tijdschr Geneeskd; 2001 Aug 11; 145(32):1541-7. PubMed ID: 11525086
    [Abstract] [Full Text] [Related]

  • 15. Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.
    Wiesenberg I, Chiesi M, Missbach M, Spanka C, Pignat W, Carlberg C.
    Mol Pharmacol; 1998 Jun 11; 53(6):1131-8. PubMed ID: 9614218
    [Abstract] [Full Text] [Related]

  • 16. Studies on the euglycemic and hypolipidemic potentials of the novel indole analogue of thiazolidinedione, DRF 2189.
    Chakrabarti R, Vikramadithyan RK, Dileepkumar T, Kumar KB, Kumar MP, Misra P, Rao PB, Lohray VB, Lohray BB, Rajagopalan R.
    Arzneimittelforschung; 1999 Nov 11; 49(11):905-11. PubMed ID: 10604043
    [Abstract] [Full Text] [Related]

  • 17. Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships.
    Arakawa K, Inamasu M, Matsumoto M, Okumura K, Yasuda K, Akatsuka H, Kawanami S, Watanabe A, Homma K, Saiga Y, Ozeki M, Iijima I.
    Chem Pharm Bull (Tokyo); 1997 Dec 11; 45(12):1984-93. PubMed ID: 9433768
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T, Matsui K, Nagao K, Shinkai H, Yonemori F, Wakitani K.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):211-9. PubMed ID: 9932726
    [Abstract] [Full Text] [Related]

  • 19. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY, Wyse BM, Gilchrist BJ, Peterson T, Diani AR.
    Diabetes; 1983 Sep 08; 32(9):830-8. PubMed ID: 6354790
    [Abstract] [Full Text] [Related]

  • 20. 5-Aryl thiazolidine-2,4-diones as selective PPARgamma agonists.
    Koyama H, Boueres JK, Han W, Metzger EJ, Bergman JP, Gratale DF, Miller DJ, Tolman RL, MacNaul KL, Berger JP, Doebber TW, Leung K, Moller DE, Heck JV, Sahoo SP.
    Bioorg Med Chem Lett; 2003 May 19; 13(10):1801-4. PubMed ID: 12729668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.